SCHEDULE M
pharmaceutical products like penicillin or biological preparations with live micro-organisms. Separate dedicated facilities shall be provided for the manufacture of contamination causing and potent products such as Beta-Lactum, sex hormones and cytotoxic substances. 3.3. Working and in-process space shall be adequate to permit orderly and
Download SCHEDULE M
Information
Domain:
Source:
Link to this page:
Documents from same domain
Role of packaging material on Pharmaceutical …
ipapharma.orgYOUR GLOBAL PARTENER IN SOLID DOSAGE SYSTEMS Role of packaging material on Pharmaceutical product stability Jnanadeva Bhat M. DGM - …
Global Long Term Stability Testing Conditions: …
ipapharma.orgGlobal Long Term Stability Testing Conditions: Position of INDIA Saranjit Singh, Ph.D. National Institute of Pharmaceutical Education and Research (NIPER),
Effective Investigations and Corrective Actions(CAPA)
ipapharma.org© Copyright, Globepharm Consulting, 2008 11 21CFR820.100 - CAPA §820.100 Corrective and preventive action (a) Each manufacturer shall …
Good Pharmacy Practice Guidelines
ipapharma.org3 The Indian Pharmaceutical Association Good Pharmacy Practice Guidelines Documentation Committee Chairman Brijesh Regal Chairman, Community Pharmacy Division, (1998-2008)
Data Integrity 483’s / Warning Letters
ipapharma.org“483’s / Warning letters related to QC Data Integrity vis-a-vis Regulatory Expectations” Ranjit Barshikar Quality by Design / cGMP Consultant ranjitbarshikar@gmail.com ...
Related documents
Annex 3 WHO good manufacturing practices for ...
www.who.intSterile solutions intended for parenteral application with a volume of 100 ml or more in one container of the fi nished dosage form. manufacture All operations of purchase of materials and products, production, quality control (QC), release, storage and distribution of pharmaceutical products, and the related controls. manufacturer
Q 7 Good Manufacturing Practice for Active Pharmaceutical ...
www.ema.europa.euapplies to the manufacture of sterile APIs only up to the point immediately prior to the APIs being rendered sterile. The sterilization and aseptic processing of sterile APIs are not covered by this guidance, but should be performed in accordance with GMP guidelines for drug (medicinal) products as defined by local authorities.
Chapter 10 Upstream Processing - Biomanufacturing
biomanufacturing.orgupstream processing is the growth of either bacterial or cell culture-based protein products, referred to as microbial fermentation or mammalian cell culture respectively. These disease-fighting proteins are collectively called Active Pharmaceutical Ingredients, or APIs